HOME >> MEDICINE >> NEWS
New data on Orqis Medical's Cancion CRS to be reported at ACC

Lake Forest, Calif. March 7, 2005 Newly analyzed research on Orqis Medical's Cancion CRSTM cardiac recovery system for treating congestive heart failure will be presented at the Annual Scientific Session of the American College of Cardiology (ACC), held in Orlando, Florida (March 6-9).

The data suggests that patients with acutely decompensated chronic heart failure may benefit from the first-of-its-kind Cancion therapy. Based on Orqis Medical's proprietary discoveries in hemodynamic principles, the therapy is designed to create a unique "rest to recovery" environment that enables the failing heart to rest as it continues to function. It represents a significant departure from conventional drug therapy and more invasive blood pumps, which either force the failing heart to work harder, or rest it to the point where it begins to atrophy.

"The patients we analyzed clearly benefited from the Cancion CRS therapy," said Michael Zile, M.D., who analyzed the research data. "By providing continuous aortic flow augmentation, the therapy enabled patients to experience progressive improvement in key measures such as cardiac index and pulmonary capillary wedge pressure."

Dr. Zile's oral presentation (AAC 864-8) is titled "Continuous Aortic Flow Augmentation Using Orqis Cancion Cardiac Recovery System in Patients with Severe Heart Failure: Determinants of the Hemodynamic Response." It will be delivered by Dr. Zile on Wednesday, March 9th at 9:45 a.m. The presentation includes data from 24 patients with congestive heart failure who participated in Orqis Medical's feasibility trials in the US and Europe.


'"/>

Contact: Erik Deutsch
erikd@excelpr.com
323-851-2455
Orqis Medical
7-Mar-2005


Page: 1

Related medicine news :

1. Orqis receives FDA approval to expand clinical trial of Cancion CRS therapy to 40 centers
2. First UK cases of previously rare disease reported in gay men
3. Decline in cardiovascular disease reported in patients with diabetes
4. Latest Asian-American tobacco use data reported
5. Study says widely reported side effect of chemotherapy may be overestimated
6. Prevalence of chronic sinusitis may be lower than commonly reported
7. Study finds vertebral fractures are underreported
8. First reported cases of North Asian tick typhus among North Americans
9. Differences in cancer screening rates reported
10. University of Pittsburgh intestine transplant results reported at international meeting
11. 1st successful national CQI intervention in medicine reported

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/31/2020)... ... August 31, 2020 , ... Colorado ... through high-quality, career-relevant, and affordable online education – is proud to announce its ... Among the first of its kind in the nation, the 60-credit hour program ...
(Date:8/31/2020)... (PRWEB) , ... August 31, 2020 , ... A Cure for Covid-19 “PTS” with Mediation ... on the planet are in a state of panic, experiencing deep anxiety, immense stress, and ... now, a solution is timely when most people on the planet are experiencing a great ...
(Date:8/31/2020)... ... August 31, 2020 , ... Bonde Innovations, ... patients with advanced heart failure, today announced that the company has been awarded ... $555,358 from the National Heart, Lung, and Blood Institute of the National Institutes ...
(Date:8/28/2020)... ... 28, 2020 , ... WHAT , Hespiro™ is a new ... conditions, including COVID-19, while reducing the need for scarce mechanical ventilators. It not ... and scrubs it free of carbon dioxide in a completely closed “rebreather” system, ...
(Date:8/28/2020)... ... August 28, 2020 , ... Integrated Viral Protection ... first Florida school to deploy its breakthrough Mobile Biodefense Indoor Air Protection System that ... North Classical Academy plans to fully reopen equipped with the filtration system on September ...
Breaking Medicine News(10 mins):
(Date:9/3/2020)... , ... September 03, 2020 , ... ... Boulder’s Vance Lab ( https://www.colorado.edu/lab/vance/masks ), an aerosol and engineering lab, conducted tests ... better protection against the COVID-19 virus than many other masks. Q&J face masks ...
(Date:9/2/2020)... ... 02, 2020 , ... U.S. Dermatology Partners is excited to welcome ... work at Bethesda Dermatopathology Lab. , Jonathan Lee, MD grew up in ... Berkley. He went on to receive his M.D. with Honors from Harvard Medical School ...
(Date:9/1/2020)... ... September 01, 2020 , ... Breast and ovarian cancers are common ... About 3% of breast cancers (about 7,500 women per year) and 10% of ovarian ... BRCA2 genes. Both genes are detectable in the Women’s Excellence Genetic Testing Program. ...
Breaking Medicine Technology:
Cached News: